Steve Przesmicki

Partner
Full contact info

Experience

Longboard Pharmaceuticals Announces $2.6 Billion Sale to Lundbeck

October 14, 2024

Cooley advised Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, on its $2.6 billion sale to Lundbeck.

Read more

Related contacts

Kevin Cooper
Partner, New York
Steve Przesmicki
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
David Burns
Special Counsel, Washington, DC
Jenny Ge
Associate, Santa Monica
Cristina Lombardi
Associate, New York
Jeewon Lee
Associate, New York
Charity Williams
Partner, San Diego
Son Nguyen
Special Counsel, Washington, DC
Stella Sarma
Special Counsel, Brussels
Ajay Athavale
Associate, San Francisco
Cara Buchicchio
Associate, New York
Elizabeth Caruso
Associate, New York
Jameson Davis
Associate, Boston
Sela Dougherty
Associate, New York
Rubin Waranch
Associate, Colorado

Related Practices & Industries

AGS Announces Definitive Agreement to Be Acquired by Brightstar Capital Partners for $1.1 Billion

May 9, 2024

Cooley advised PlayAGS, a global gaming supplier of high-performing slots, tables and interactive products, on its definitive agreement to be acquired by the affiliates of Brightstar Capital Partners for $1.1 billion.

Read more

Related contacts

Miguel J. Vega
Partner, Boston
Steve Przesmicki
Partner, San Diego
David Silverman
Partner, New York
Natalie D. Vernon
Associate, Colorado
Rachel Shapiro
Associate, Colorado
Barbara Mirza
Partner, Santa Monica
Alexander Ellebracht
Associate, Palo Alto
Alexandra Leavy
Associate, New York
Peter Adams
Partner, San Diego
Megan Browdie
Partner, Washington, DC
Thomas Connors
Partner, Boston
Kevin Cooper
Partner, New York
Ross Eberly
Partner, Santa Monica
Patrick Flanagan
Partner, New York
Todd Gluth
Partner, San Diego
Kristopher Kleiner
Special Counsel, Colorado
Christine Graham
Special Counsel, London
Stella Sarma
Special Counsel, Brussels
Karen Tsai
Special Counsel, Washington, DC
Alexis Guillermo Buz
Associate, San Diego
James Christopher
Associate, Boston
Joshua Elefant
Associate, Palo Alto
Jimmy Gilligan
Associate, Boston
Katie Kaufman
Associate, Washington, DC
Rachel F. Katz
Associate, New York
Allison Kutner
Associate, New York
Kyrsten Lundh
Associate, San Diego
Sangitha Palaniappa
Associate, Palo Alto
María Álvarez Requejo Heredero
Associate, Brussels
Sarah Buchik
Associate, New York

Related Practices & Industries

Seven and Eight Biopharma Announces Global License, Collaboration Agreement With Eikon

June 14, 2023

Cooley advised Seven and Eight Biopharmaceuticals, clinical-stage biotechnology company focused on the development and commercialization of novel immunotherapies for cancer, on its license and collaboration agreement with Eikon Therapeutics, a biotechnology company.

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Steve Przesmicki
Partner, San Diego
Bin Wang
Special Counsel, Palo Alto
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion

December 15, 2021

Cooley advised Arena Pharmaceuticals, a clinical-stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases, on its definitive agreement to sell to Pfizer for $6.7 billion. Partners Jamie Leigh, Kevin Cooper and Steve Przesmicki led the Cooley team advising Arena.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Kevin Cooper
Partner, New York
Steve Przesmicki
Partner, San Diego
Jeffrey J. Tolin
Partner, New York
Alexander Israel
Partner in Charge – Brussels, Brussels
Barbara Mirza
Partner, Santa Monica
Peter Adams
Partner, San Diego
Phil Mitchell
Partner, New York
Mika Reiner Mayer
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Matthew D. Silverman
Special Counsel, Santa Monica
Christine Graham
Special Counsel, London
Stella Sarma
Special Counsel, Brussels
Asa Henin
Special Counsel, San Diego
Sangitha Palaniappa
Associate, Palo Alto
Heidi E. Wang
Associate, San Diego
Peter Burns
Of Counsel, Palo Alto
Eileen Leman
Associate, Los Angeles
Ross Eberly
Partner, Santa Monica
Kyrsten Lundh
Associate, San Diego
Allison Kutner
Associate, New York
Andrew Epstein
Special Counsel, Seattle
Dionne A. Thomas
Associate, San Diego
Dr. Madhuri Roy
Partner, Palo Alto

Related Practices & Industries

Dynavax Technologies – $200 Million Convertible Notes Offering

May 11, 2021

Cooley advised Dynavax Technologies on its offering of $200 million principal amount of 2.50% convertible senior notes due 2026. Dynavax Technologies, whose securities trade on the Nasdaq Capital Market under the symbol DVAX, is a biopharmaceutical company focused on developing and commercializing novel vaccines. Partners Steve Przesmicki, Mischi a Marca and Jason Savich le the Cooley team.

Related contacts

Steve Przesmicki
Partner, San Diego
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Marina Remennik
Special Counsel, Palo Alto
Ron Metzger
Paralegal Specialist, San Francisco
Timothy Nguyen
Special Counsel, San Francisco
Ellie Seber
Partner, Santa Monica
Matt Kong
Associate, San Francisco
Xueqing Li
Associate, San Francisco
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

View more

Admissions and credentials

California

Wisconsin

Rankings and accolades

Best Lawyers in America: Corporate Law

San Diego Super Lawyers

Southern California Super Lawyers